Skip to Content

Coartem Approval History

FDA Approved: Yes (First approved April 7, 2009)
Brand name: Coartem
Generic name: artemether and lumefantrine
Dosage form: Tablets
Company: Novartis
Treatment for: Malaria

Coartem (artemether and lumefantrine) is an artemisinin-based combination treatment for the treatment of malaria.

Development History and FDA Approval Process for Coartem

DateArticle
Apr  8, 2009Approval Coartem receives FDA approval becoming first artemisinin-based combination treatment (ACT) for malaria in the US

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide